Insulin aspart, recombinant Subcutaneous and Sopamycetin Ophthalmic
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Sopamycetin Ophthalmic and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: chloramphenicol ophthalmic
Brand name:
Synonyms: Chloramphenicol (Ophthalmic)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Sopamycetin Otic
- Insulin aspart, recombinant Subcutaneous-Sorafenib
- Insulin aspart, recombinant Subcutaneous-Sorafenib Tosylate
- Insulin aspart, recombinant Subcutaneous-Sorbitol
- Insulin aspart, recombinant Subcutaneous-Sorbitol Irrigation Solution
- Insulin aspart, recombinant Subcutaneous-Sorbitol Solution
- Sopamycetin Ophthalmic-Insulin degludec
- Sopamycetin Ophthalmic-Insulin Degludec (U-100) Prefilled Pens
- Sopamycetin Ophthalmic-Insulin Degludec (U-100) Vials
- Sopamycetin Ophthalmic-Insulin Degludec (U-200) Prefilled Pens
- Sopamycetin Ophthalmic-Insulin degludec and liraglutide
- Sopamycetin Ophthalmic-Insulin degludec and liraglutide Subcutaneous